Penumbra Inc
PENNYSE
$318.32
↓ -0.4%Jul 17 close · end-of-day
Price
1Y↑ +35.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$12.6B
Enterprise Value
$12.0B
P/E
73.3
P/S
8.7
P/B
8.5
EV/EBITDA
58.6
PEG
—
FCF Yield
1.7%
Dividend Yield
—
Revenue (TTM)
$1.5B
Net Income (TTM)
$171.0M
Free Cash Flow (TTM)
$212.7M
Gross Margin
67.4%
Operating Margin
12.9%
Net Margin
11.8%
ROE
11.6%
ROIC
18.4%
Debt / Equity
—
Net Cash
$615.7M
Return 1Y
+38.3%
Company profile
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand.
- CEO
- Adam Elsesser
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 3,900
- Headquarters
- California
- Website
- penumbrainc.com
Management & directors
- Elsesser AdamCEO and President
- Narayan ShruthiPresident
- Roberts JohannaEVP, Gen. Counsel & Secretary
- Shiu LambertChief Accounting Officer
- Yuen MaggieChief Financial Officer
Roles derived from SEC Form 4 filings.
Earnings
PEN Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$374.8M↑ +15.6%
Diluted EPS$0.82↓ -18.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $560.4M | $747.6M | $847.1M | $1.1B | $1.2B | $1.4B |
| Gross profit | $338.2M | $475.4M | $535.2M | $682.6M | $755.0M | $942.4M |
| Operating income | -$38.9M | -$7.5M | $6.1M | $73.6M | $9.3M | $189.2M |
| Net income | -$15.7M | $5.3M | -$2.0M | $91.0M | $14.0M | $177.7M |
| Diluted EPS | -$0.44 | $0.14 | -$0.05 | $2.32 | $0.36 | $4.52 |
| Operating cash flow | -$33.2M | $9.5M | -$55.7M | $97.3M | $168.5M | $238.7M |
| Free cash flow | -$58.0M | -$11.7M | -$75.0M | $82.1M | $147.3M | $174.9M |
| Gross margin | 60.3% | 63.6% | 63.2% | 64.5% | 63.2% | 67.1% |
| Operating margin | -6.9% | -1.0% | 0.7% | 6.9% | 0.8% | 13.5% |
| Net margin | -2.8% | 0.7% | -0.2% | 8.6% | 1.2% | 12.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $299.4M | $301.0M | $315.5M | $324.1M | $339.5M | $354.7M | $385.4M | $374.8M |
| Gross profit | $162.8M | $200.3M | $210.7M | $215.9M | $224.0M | $240.4M | $262.1M | $253.4M |
| Operating income | -$81.0M | $35.4M | $42.8M | $40.4M | $40.8M | $48.8M | $59.2M | $38.2M |
| Net income | -$60.2M | $29.5M | $33.7M | $39.2M | $45.3M | $45.9M | $47.3M | $32.6M |
| Diluted EPS | -$1.55 | $0.75 | $0.88 | $1.00 | $1.15 | $1.17 | $1.20 | $0.82 |
| Operating cash flow | $22.6M | $56.5M | $51.1M | $49.0M | $44.9M | $58.3M | $86.5M | $87.0M |
| Free cash flow | $18.1M | $51.0M | $45.7M | $35.5M | $29.4M | $42.0M | $68.0M | $73.3M |
| Gross margin | 54.4% | 66.5% | 66.8% | 66.6% | 66.0% | 67.8% | 68.0% | 67.6% |
| Operating margin | -27.0% | 11.7% | 13.6% | 12.4% | 12.0% | 13.8% | 15.4% | 10.2% |
| Net margin | -20.1% | 9.8% | 10.7% | 12.1% | 13.3% | 12.9% | 12.3% | 8.7% |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-19 | Elsesser Adam· CEO | Gift | 77,000 | $0.00 | $0.00 | filing |
| 2026-04-02 | Grewal Harpreet | Sale | 100 | $328.22 | $32,822.00 | filing |
| 2026-03-15 | Roberts Johanna· EVP, Gen. Counsel & Secretary | Tax withholding | 186 | $336.18 | $62,529.48 | filing |
| 2026-03-15 | Yuen Maggie· Chief Financial Officer | Tax withholding | 186 | $336.18 | $62,529.48 | filing |
| 2026-03-15 | Shiu Lambert· Chief Accounting Officer | Tax withholding | 150 | $336.18 | $50,427.00 | filing |
| 2026-03-15 | Narayan Shruthi· President | Tax withholding | 117 | $336.18 | $39,333.06 | filing |
| 2026-03-02 | Yuen Maggie· Chief Financial Officer | Sale | 2,432 | $342.30 | $832,473.60 | filing |
| 2026-02-17 | Roberts Johanna· EVP, Gen. Counsel & Secretary | Award | 2,630 | $0.00 | $0.00 | filing |
| 2026-02-17 | Yuen Maggie· Chief Financial Officer | Award | 2,630 | $0.00 | $0.00 | filing |
| 2026-02-17 | Shiu Lambert· Chief Accounting Officer | Award | 2,300 | $0.00 | $0.00 | filing |
| 2026-02-17 | Narayan Shruthi· President | Award | 2,630 | $0.00 | $0.00 | filing |
| 2026-02-15 | Narayan Shruthi· President | Tax withholding | 705 | $339.30 | $239,206.50 | filing |
| 2026-02-15 | Roberts Johanna· EVP, Gen. Counsel & Secretary | Tax withholding | 482 | $339.30 | $163,542.60 | filing |
| 2026-02-15 | Yuen Maggie· Chief Financial Officer | Tax withholding | 481 | $339.30 | $163,203.30 | filing |
| 2026-02-15 | Shiu Lambert· Chief Accounting Officer | Tax withholding | 412 | $339.30 | $139,791.60 | filing |
| 2026-02-13 | Grewal Harpreet | Award | 589 | $0.00 | $0.00 | filing |
| 2026-02-13 | Bose Arani | Award | 589 | $0.00 | $0.00 | filing |
| 2026-02-13 | Leeds Janet | Award | 589 | $0.00 | $0.00 | filing |
| 2026-02-13 | O'Rourke Bridget | Award | 589 | $0.00 | $0.00 | filing |
| 2026-02-13 | Sarna Surbhi | Award | 589 | $0.00 | $0.00 | filing |
| 2026-02-13 | Wilder Thomas | Award | 589 | $0.00 | $0.00 | filing |
| 2026-02-13 | Roberts Johanna· EVP, Gen. Counsel & Secretary | Award | 2,630 | $0.00 | $0.00 | filing |
| 2026-02-13 | Yuen Maggie· Chief Financial Officer | Award | 2,630 | $0.00 | $0.00 | filing |
| 2026-02-13 | Shiu Lambert· Chief Accounting Officer | Award | 2,300 | $0.00 | $0.00 | filing |
| 2026-02-13 | Narayan Shruthi· President | Award | 2,630 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.